10/6/2023 | BK | Horizon repays, redeems over $2.6 billion in debt in Amgen acquisition
|
5/16/2023 | BK | Market Commentary: Horizon lower with acquisition issues; Ascend falls; Wencor gains; Cvent accelerated
|
2/15/2023 | BKGNHYIG | Moody’s assigns Amgen notes Baa1
|
2/14/2023 | BKGNHYIG | S&P assigns Amgen notes BBB+
|
2/14/2023 | BKGNHYIG | Fitch rates Amgen loans, notes BBB+
|
2/13/2023 | BKGNHYIG | Moody’s turns Amgen outlook to negative
|
12/13/2022 | BKGNHYIG | S&P puts Horizon on positive watch
|
12/13/2022 | BKGNHYIG | Moody's eyes Horizon for upgrade
|
12/12/2022 | BKGNHYIG | Moody's eyes Amgen downgrade
|
12/12/2022 | BKGNHYIG | S&P snips Amgen
|
12/12/2022 | BKGNHYIG | Fitch places Amgen on watch
|
3/18/2022 | BKHY | Moody's upgrades Horizon Therapeutics
|
3/17/2021 | BKHY | S&P lowers Horizon debt ratings
|
2/16/2021 | BK | Market Commentary: DigiCert, Victory Capital, Blackstone break; RealPage, Liftoff, Ivanti accelerate deadlines
|
2/16/2021 | BK | Horizon Therapeutics to launch new loan on Wednesday afternoon
|
2/12/2021 | BK | Horizon Therapeutics adds JPMorgan to $1.3 billion term loan
|
2/8/2021 | BK | Horizon Therapeutics plans $1.3 billion term loan for Viela purchase
|
2/8/2021 | BKHY | S&P puts Horizon debt ratings on watch
|
1/26/2021 | BKHY | S&P ups Horizon Therapeutics
|
6/11/2020 | BKCVHY | S&P cuts Horizon Therapeutics notes
|
2/4/2020 | BKHY | Moody's: Horizon Therapeutics view to positive
|
12/4/2019 | BK | Market Commentary: Canister, Chesapeake Energy, JBS, Herbalife, Walker & Dunlop, Cabot float price talk
|
12/4/2019 | BK | Horizon Therapeutics schedules Thursday call for loan lenders
|
10/9/2019 | BKHY | S&P ups Horizon Therapeutics unsecured rating to BB-
|
7/16/2019 | BK | Horizon Pharma USA pays down $100 million of secured term loans
|
7/10/2019 | BKHY | Moody’s rates Horizon Pharma notes B1
|
7/10/2019 | BKHY | S&P rates Horizon Pharma notes B+
|
5/17/2019 | BK | Market Commentary: Berry Global, Delek, Horizon break; Hudson River sets changes; Lucid accelerates deadline
|
5/16/2019 | BK | Market Commentary: Horizon update surfaces; McGraw-Hill/Cengage tables loan; Cetera, Nautilus disclose talk
|
5/16/2019 | BK | Horizon Therapeutics revises OID on $518 million term loan to 99.875
|
5/15/2019 | BK | Fitch cuts Lucid Energy, rates loan BB-
|
5/15/2019 | BKHY | Moody’s rates Horizon Pharma loan Ba1
|
5/9/2019 | BK | Market Commentary: Catalent Pharma, LightBox, ThoughtWorks break; Oryx Midstream, FirstLight revise deals
|
5/9/2019 | BK | Horizon launches $518 million term loan B at Libor plus 250 bps
|
5/8/2019 | BK | Market Commentary: Kontoor, II-VI, Wells Enterprises free up; ThoughtWorks revised; Jefferies, Sirius set talk
|
5/8/2019 | BK | Horizon Therapeutics to launch new loan transaction on Thursday
|